Transform Your Driving Experience with Expert Exhaust Repair in Dubai!
Your car’s exhaust system plays a bigger...
The Continuous Glucose Monitoring Market is expected to reach $31.41 billion by 2031
Meticulous Research® has recently published a report forecasting the global continuous glucose monitoring (CGM) market to soar to $31.41 billion by 2031, growing at a robust compound annual growth rate (CAGR) of 15% between 2024 and 2031. This growth is largely fueled by several key factors, including the rising prevalence of diabetes, the increasing number of individuals leading sedentary lifestyles, and the clear advantages of continuous glucose monitoring systems over traditional glucose monitoring methods. Additionally, the adoption of CGM devices by athletes and fitness enthusiasts is contributing to market expansion. The report further highlights that advancements in CGM technology, the shift towards personalized healthcare, heightened health awareness, and improved access to diabetes care devices in low- and middle-income countries are expected to provide substantial growth opportunities.Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=08-08-2024
Leading Companies in the CGM Market
The report offers an in-depth analysis of the top players in the CGM market, examining their product portfolios, geographical presence, and strategic approaches over the past three to four years. The continuous glucose monitoring sector has seen a series of both organic and inorganic strategic developments in recent times. Notable companies profiled in the report include DexCom, Inc. (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (U.K.), LifeScan, Inc. (U.S.), Senseonics Holdings, Inc. (Maryland), A. Menarini Diagnostics S.r.l (Italy), Medtrum Technologies, Inc. (China), and B. Braun Melsungen SE (Germany).
Market Segmentation Insights
The continuous glucose monitoring market is segmented based on components (including Sensors [Disposable Sensors, Implantable Sensors], Transmitters, and Receivers), age group (Adults and Children), end-user (Home Care Settings and Hospitals & Clinics), and geography.
In 2024, the sensors segment is projected to command the largest portion of the market, with a share of 52.4%. This dominance is attributed to significant technological advancements in sensor technology, the availability of disposable sensors, and the increasing adoption of CGM systems over conventional glucometers. The high replacement rate of sensors compared to other components also plays a crucial role, as repeat purchases of sensors significantly contribute to the market’s growth.
Browse in depth: https://www.meticulousresearch.com/product/continuous-glucose-monitoring-market-5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=08-08-2024
When analyzing the market by age group, the adults segment is expected to hold the largest share of the CGM market in 2024. This can be traced to the high prevalence of diabetes among adults, the growing adoption of wearable devices, and an increasing focus on preventive healthcare. The adult population has a higher incidence of diabetes compared to children, which in turn drives greater demand for CGM devices within this age group.
In terms of end users, the home care settings segment is anticipated to account for the majority share of over 82.3% of the market by 2024. The rise in the elderly population and the growing burden of diabetes have amplified the need for self-monitoring and home care solutions. CGM systems designed for home use offer several benefits, including easier access, reduced travel time to healthcare facilities, enhanced awareness of diabetes management, and a broader shift towards preventive care.
Download request sample report here:https://www.meticulousresearch.com/request-sample-report/cp_id=5960?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=08-08-2024
Regional Market Dynamics
Geographically, North America is projected to hold the largest share of the CGM market, accounting for over 42.2% in 2024. The region’s leading position can be attributed to factors such as a strong emphasis on patient engagement, a shift towards preventive healthcare, and widespread awareness and accessibility to CGM devices, particularly due to the availability of reimbursement options in developed countries. For example, a study by One Drop, a U.S.-based precision health solutions provider for diabetes and chronic conditions, found that approximately 2.4 million Americans were using CGM devices in 2022. This number is expected to grow significantly, further boosting the market share in North America.
Quick buy: https://www.meticulousresearch.com/Checkout/64947495?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=08-08-2024
Key Questions Addressed in the Report:
- What are the fastest-growing market segments by component, age group, end user, and geography?
- How has the global market for continuous glucose monitoring evolved historically?
- What are the market projections and estimates for the period 2024–2031?
- What are the primary drivers, challenges, opportunities, and threats in the CGM market?
- Who are the leading players in the continuous glucose monitoring market?
- What is the competitive landscape of the market?
- What recent developments have occurred in the CGM sector?
- What strategies are major players employing in the continuous glucose monitoring market?
- What are the regional trends and high-growth areas in the CGM market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post